Why is Akums Drugs falling/rising?

As of 23-Jun, Akums Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 534.60, which reflects a decrease of 8.0 points or 1.47%. The stock has underperformed its sector by 1.46% today, and its performance over the past week shows a significant drop of 7.23%. Additionally, the stock's delivery volume has decreased by 36.42% compared to the 5-day average, indicating falling investor participation. While the company has reported positive quarterly results with record net sales and profits, its long-term growth prospects appear weak, with net sales growing at an annual rate of only 6.10% over the last five years.
In the broader market context, the Sensex has shown a slight increase of 0.12% over the past week, contrasting with Akums Drugs' significant decline. This underperformance is further highlighted by the stock's year-to-date return of -16.22%, while the benchmark has gained 4.81%. Despite the company's attractive valuation and strong quarterly performance, the lack of long-term growth and declining investor interest are contributing to the stock's downward movement.